Allogeneic UCB Therapy With EPO in Children With CP

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01991145
Recruitment Status : Completed
First Posted : November 25, 2013
Last Update Posted : October 12, 2017
Ministry of Health & Welfare, Korea
LG Life Sciences
Chong Kun Dang Pharmaceutical
CHA University
Information provided by (Responsible Party):
MinYoung Kim, M.D., Bundang CHA Hospital

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : June 24, 2017
  Actual Study Completion Date : June 24, 2017